The immune response to numerous antigens administered parenterally can be suppressed or reduced by prior oral treatment with the same antigen. This applies to both particulate (1, 2) and soluble (3-5) antigens. The immune tolerance thus produced is specific and can be shown to affect cell-mediated hypersensitivity (6) as well as the production of specific antibody, including reaginic antibody (7, 8) .
of One Oral Dose of 0 VA (Figs. 1-3 ). When AKR mice were given 20 mg OVA orally 15 d before intraperitoneal immunization with 1 mg OVA (no adjuvant), the antibody response was greatly augmented in the majority of eases (group B). This did not occur in DBA/2 or C3H mice. (Fig. 4) . AKR 
Repeated Administration of Oral 0 VA Diminishes Reaginic Antibody Production in Sensitized Animals

Discussion
It is difficult to induce immune tolerance after an initial immunization procedure (10, 13). Here we show that repeated oral administration of antigen (OVA) is necessary to prevent secondary antibody responses in mice previously parenterally immunized. This is in contrast with other studies (4) (5) (6) (7) (8) , and is at variance with the recent studies that failed to demonstrate suppression of the secondary response (10, 13). They did not study the effect of repeated oral administration of antigen. It is, however, well established that repeated stimulation of Peyer's patch suppressor T cells with OVA is necessary to suppress the effect of primary parenteral immunization (8, (14) (15) (16) (17) . The possibility of antibody blocking by increased intestinal absorption of the antigen may be ruled out for two reasons. (a) Local antibodies produced after oral administration of antigens markedly decrease its absorption (18) . (b) The oral administration of larger doses (25 rag/d) and for a longer period (14 d) of OVA in C3H mice resulted in a nonsignificant amount of circulating antigen when assessed by radioimmunoassay in a time protocol very similar to our own (4).
Our results varied with the strain of mouse used, as previously described (19) . Inconsistent results were obtained with DBA/2 mice, good suppression was seen in the C3H strain, and the best results were obtained using AKR mice, in which a clear reduction in the secondary response occurred with four doses of oral antigen. We have also noticed that suppression of a primary response by prior ingestion of antigen is difficult to obtain in DBA/2 mice, but occurs readily in C3H and AKR (unpublished data). It therefore appears that induction of tolerance is genetically determined and is identical for both primary and secondary responses.
Our interest in the reaginic antibody response in AKR mice was prompted by the observation that all the animals were in anaphylactic shock for at least 1 h after the second intraperitoneal dose of OVA at day 30. However, when one oral dose was given 15 d after sensitization, 4 out of 10 mice went into shock, 3 of 10 died, and 3 remained healthy. We found a substantial IgE response 30 d after primary immunization, although the dose of OVA was quite high (1 mg) and none of the usual adjuvants necessary to elicit reaginic responses were used. An oral dose of 20 mg does not provoke reaginic response (Fig. 4, group A) . Other authors (20) have found reaginic responses with minute doses of OVA by the oral route. We have shown that one dose of oral OVA at day 15 after intraperitoneal sensitization does not diminish the IgE response at day 30, and may occasionally induce IgG1. However, when four oral doses of OVA are given on consecutive days (days [15] [16] [17] [18] , reaginic antibodies become almost undetectable in the serum at day 30. Similar results are obtained with 10 oral doses on days 15-19 and 21-25 . A new intraperitoneal sensitization at day 30 does not provoke any shocks in AKR mice after 4 or 10 oral doses.
We have confirmed, as previously suggested (21) , that oral ingestion of antigen could reduce anaphylactic reactions in sensitized subjects. Recently, it has been shown that repeated intraperitoneal injections of OVA can reduce reaginic antibody titers 1 mo after sensitization (22) . It therefore seems possible that desensitization occurs as a result of repeated exposure to relatively small amounts of absorbed antigen.
The possible reduction in intensity of a secondary humoral response by repeated ingestion of antigen has important clinical implications. That this is more than a theoretical possibility has been demonstrated by Bierme et al. (23) , who reported the beneficial effect of feeding rhesus antigens to extremely immunized mothers.
Summary
We have investigated the possibility of oral administration of ovalbumin (OVA) to prevent a secondary antibody reponse and interrupt reaginic antibody production. Repeated feeding seems necessary for both. Quality of results was dependent on the number of ingestions. Differences in abrogation of antibody response between mice strains were observed. Best results were obtained with AKR mice, good suppression was seen in C3H strain, and inconsistent results were obtained with DBA/2. 10 OVA oral doses were necessary to prevent a secondary antibody response in parenterally immunized mice, but 4 doses interrupted reaginic production in sensitized AKR mice. These results demonstrate that antigen feeding can prevent a secondary antibody response and interrupt reaginic antibody production. 3 March 1982. 
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